\-\ Texto\\:\\ \ \(0\)\
\-\ located\\ in\\ the\\ left\\ lateral\\ convexity\\ of\\ the\\ cranial\\ vault\\ is\\ a\\ well\\-\\ circumscribed\\,\\ peripherally\\ based\\,\\ extra\\-axial\\ lesion\\ that\\ is\\ nearly\\ isointense\\ to\\ cerebral\\ cortex\\ on\\ both\\ t1\\ and\\ t2\\ imaging\\ sequences\\.\\ the\\ lesion\\ also\\ demonstrates\\ intense\\ homogeneous\\ enhancement\\ following\\ administration\\ of\\ gadolinium\\.\\ there\\ is\\ evident\\ thickening\\ and\\ abnormal\\ enhancement\\ of\\ the\\ adjacent\\ meninges\\ consistent\\ with\\ a\\ \\‚\\Ä\\údural\\ tail\\ sign\\,\\"\\ which\\ is\\ most\\ commonly\\ associated\\ with\\ a\\ meningioma\ \(0\)\
\-\ meningioma\ \(167\)\
\-\ 70\\ yo\\ man\\ with\\ a\\ 3\\ month\\ history\\ of\\ transient\\ episodes\\ of\\ right\\ upper\\ extremity\\ weakness\\,\\ dysarthria\\,\\ and\\ expressive\\ aphasia\\ which\\ was\\ refractory\\ to\\ aspirin\\ and\\ ticlopidine\\ therapy\\.\\ past\\ medical\\ history\\ was\\ significant\\ only\\ for\\ hypertension\\.\\ on\\ admission\\,\\ ct\\ \\(without\\ contrast\\)\\ was\\ negative\\ for\\ hemorrhage\\ and\\ masses\\.\ \(0\)\
\-\ meningiomas\\ account\\ for\\ 13\\ to\\ 18\\ percent\\ of\\ intracranial\\ tumors\\.\\ they\\ demonstrate\\ a\\ female\\ predominance\\,\\ and\\ occur\\ primarily\\ in\\ adults\\ from\\ ages\\ 20\\ to\\ 60\\,\\ with\\ a\\ peak\\ age\\ of\\ 45\\ years\\.\\ \\ clinical\\ symptoms\\ are\\ usually\\ nonspecific\\,\\ consisting\\ of\\ headache\\,\\ visual\\ impairment\\,\\ and\\ seizures\\,\\ but\\ focal\\ weakness\\ and\\ numbness\\ in\\ an\\ opposite\\ extremity\\ may\\ be\\ present\\ if\\ the\\ mass\\ compresses\\ the\\ brain\\ around\\ the\\ rolandic\\ fissure\\.\\ \ \(0\)\
\-\ meningiomas\\ are\\ normally\\ benign\\ tumors\\ \\(who\\ grade\\ 1\\)\\ arising\\ from\\ meningothelial\\ cells\\ \\(arachnoid\\ villi\\)\\.\\ the\\ parasagittal\\ region\\ is\\ the\\ most\\ frequent\\ site\\ for\\ meningiomas\\,\\ followed\\ by\\ the\\ cranial\\ convexity\\,\\ sphenoid\\ wings\\,\\ parasellar\\ region\\,\\ olfactory\\ groove\\,\\ cerebellopontine\\ angle\\,\\ and\\ the\\ intraventricular\\ region\\ \\(rare\\)\\.\\ ninety\\ percent\\ of\\ meningiomas\\ are\\ supratentorial\\,\\ with\\ two\\ thirds\\ occurring\\ in\\ the\\ anterior\\ half\\ of\\ the\\ skull\\.\\ \\ lesions\\ are\\ usually\\ single\\,\\ but\\ in\\ 1\\ to\\ 2\\ percent\\ of\\ cases\\ they\\ are\\ multiple\\.\\ multiple\\ meningiomas\\ are\\ usually\\ seen\\ in\\ association\\ with\\ neurofibromatosis\\ type\\ 2\\.\\ \ \(0\)\
\-\ blood\\ supply\\ to\\ the\\ lesion\\ usually\\ comes\\ from\\ meningeal\\ branches\\ of\\ the\\ external\\ carotid\\ artery\\ or\\,\\ less\\ commonly\\,\\ from\\ meningeal\\ branches\\ of\\ the\\ internal\\ carotid\\ and\\ vertebral\\ arteries\\.\ \(0\)\
\-\ on\\ mri\\,\\ the\\ majority\\ of\\ meningiomas\\ have\\ a\\ signal\\ intensity\\ similar\\ to\\ that\\ of\\ gray\\ matter\\ on\\ all\\ sequences\\.\\ densely\\ calcified\\ lesions\\ may\\ be\\ hypointense\\ on\\ imaging\\.\\ t1\\-weighted\\ \\ images\\ often\\ provide\\ the\\ best\\ description\\ of\\ anatomic\\ distortion\\ and\\ displacement\\ of\\ cerebral\\ cortex\\ and\\ adjacent\\ white\\ matter\\ \\(white\\ matter\\ buckling\\)\\,\\ a\\ sign\\ of\\ an\\ extra\\-axial\\ lesion\\.\\ an\\ interface\\ between\\ brain\\ parenchyma\\ and\\ lesion\\ can\\ often\\ be\\ identified\\;\\ this\\ may\\ be\\ related\\ to\\ a\\ csf\\ cleft\\,\\ a\\ vascular\\ rim\\,\\ or\\ a\\ dural\\ margin\\.\\ a\\ csf\\ cleft\\ sign\\ is\\ best\\ seen\\ as\\ a\\ rim\\ of\\ hyperintensity\\ on\\ t2\\-weighted\\ images\\.\ \(0\)\
\-\ meningiomas\\ show\\ intense\\ enhancement\\ with\\ gadolinium\\ and\\ are\\ sharply\\ circumscribed\\.\\ they\\ have\\ a\\ characteristic\\ broad\\ base\\ of\\ dural\\ attachment\\,\\ but\\ this\\ may\\ be\\ evident\\ only\\ with\\ imaging\\ in\\ sagittal\\ or\\ coronal\\ planes\\.\\ an\\ enhancing\\ \\‚\\Ä\\údural\\ tail\\‚\\Ä\\ù\\ may\\ be\\ seen\\ in\\ up\\ to\\ 60\\ percent\\ of\\ meningiomas\\.\\ in\\ the\\ majority\\ of\\ cases\\,\\ this\\ is\\ a\\ reactive\\ phenomenon\\ and\\ does\\ not\\ represent\\ tumor\\ extension\\ to\\ the\\ dura\\.\\ mass\\ effect\\ may\\ be\\ mild\\ and\\ less\\ than\\ would\\ he\\ expected\\ for\\ the\\ size\\ of\\ the\\ tumor\\.\\ this\\ is\\ explained\\ by\\ resulting\\ local\\ pressure\\ atrophy\\ occurring\\ at\\ a\\ rate\\ similar\\ to\\ tumor\\ growth\\.\\ \ \(0\)\
\-\ meningiomas\\ may\\ erode\\ adjacent\\ bone\\ or\\ stimulate\\ new\\ bone\\ formation\\.\\ \\ hyperostosis\\ may\\ or\\ may\\ not\\ be\\ associated\\ with\\ bone\\ invasion\\ by\\ meningioma\\ cells\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ meningiomas\\:\\ 0\\.44363087433361675\ \(0\)\
\-\ may\\:\\ 0\\.1906378554211406\ \(0\)\
\-\ of\\:\\ 0\\.1894556788062496\ \(0\)\
\-\ the\\:\\ 0\\.18477501319849599\ \(0\)\
\-\ percent\\:\\ 0\\.16650572957346838\ \(0\)\
\-\ dural\\:\\ 0\\.14941021001515575\ \(0\)\
\-\ and\\:\\ 0\\.13916449574295867\ \(0\)\
\-\ be\\:\\ 0\\.13660009002371004\ \(0\)\
\-\ to\\:\\ 0\\.11575188441965407\ \(0\)\
\-\ are\\:\\ 0\\.11180379861418105\ \(0\)\
\-\ usually\\:\\ 0\\.10599370542862993\ \(0\)\
\-\ lesion\\:\\ 0\\.10089902617444117\ \(0\)\
\-\ matter\\:\\ 0\\.09614844530445958\ \(0\)\
\-\ meningeal\\:\\ 0\\.09466344506225735\ \(0\)\
\-\ meningioma\\:\\ 0\\.0946211710012363\ \(0\)\
\-\ in\\:\\ 0\\.09423994408713075\ \(0\)\
\-\ convexity\\:\\ 0\\.09238852044999413\ \(0\)\
\-\ is\\:\\ 0\\.09221727720239019\ \(0\)\
\-\ they\\:\\ 0\\.09022638652348913\ \(0\)\
\-\ sign\\:\\ 0\\.08742221720468409\ \(0\)\
\-\ occurring\\:\\ 0\\.08493443116263416\ \(0\)\
\-\ branches\\:\\ 0\\.08348167244157757\ \(0\)\
\-\ tail\\:\\ 0\\.08302755051529345\ \(0\)\
\-\ adjacent\\:\\ 0\\.08185197910799677\ \(0\)\
\-\ intense\\:\\ 0\\.07946852956766252\ \(0\)\
\-\ majority\\:\\ 0\\.07645923464340236\ \(0\)\
\-\ on\\:\\ 0\\.07627490318520015\ \(0\)\
\-\ cleft\\:\\ 0\\.07603553669691378\ \(0\)\
\-\ region\\:\\ 0\\.075532461211412\ \(0\)\
\-\ with\\:\\ 0\\.07417912638098799\ \(0\)\
\-\ or\\:\\ 0\\.07321515611621199\ \(0\)\
\-\ enhancement\\:\\ 0\\.07268213799616287\ \(0\)\
\-\ evident\\:\\ 0\\.07235766035692366\ \(0\)\
\-\ carotid\\:\\ 0\\.07091168527106605\ \(0\)\
\-\ gadolinium\\:\\ 0\\.0701448739337907\ \(0\)\
\-\ bone\\:\\ 0\\.06889999869937431\ \(0\)\
\-\ cranial\\:\\ 0\\.06880639238983119\ \(0\)\
\-\ cortex\\:\\ 0\\.06855267041353494\ \(0\)\
\-\ best\\:\\ 0\\.06773711495832485\ \(0\)\
\-\ sequences\\:\\ 0\\.0673456384732117\ \(0\)\
\-\ ticlopidine\\:\\ 0\\.06731415160842949\ \(0\)\
\-\ rim\\:\\ 0\\.06703976642332385\ \(0\)\
\-\ from\\:\\ 0\\.06686851248500361\ \(0\)\
\-\ csf\\:\\ 0\\.06651928635044999\ \(0\)\
\-\ imaging\\:\\ 0\\.06636219331870367\ \(0\)\
\-\ tumor\\:\\ 0\\.06604955687487253\ \(0\)\
\-\ circumscribed\\:\\ 0\\.06519263402810273\ \(0\)\
\-\ cells\\:\\ 0\\.06486246817446069\ \(0\)\
\-\ an\\:\\ 0\\.06438324340519483\ \(0\)\
\-\ rolandic\\:\\ 0\\.06432226550425246\ \(0\)\
\-\ meningothelial\\:\\ 0\\.06432226550425246\ \(0\)\
\-\ ninety\\:\\ 0\\.06432226550425246\ \(0\)\
\-\ similar\\:\\ 0\\.06416110172543664\ \(0\)\
\-\ for\\:\\ 0\\.06378869721696853\ \(0\)\
\-\ 60\\:\\ 0\\.06296548478328567\ \(0\)\
\-\ but\\:\\ 0\\.06244356814880205\ \(0\)\
\-\ commonly\\:\\ 0\\.06229200831706243\ \(0\)\
\-\ tumors\\:\\ 0\\.06191288806728081\ \(0\)\
\-\ weakness\\:\\ 0\\.061439335199261966\ \(0\)\
\-\ extremity\\:\\ 0\\.060633248261651194\ \(0\)\
\-\ erode\\:\\ 0\\.06055293479036199\ \(0\)\
\-\ seen\\:\\ 0\\.05944961252340268\ \(0\)\
\-\ villi\\:\\ 0\\.05920760242672433\ \(0\)\
\-\ cerebral\\:\\ 0\\.05832334425847866\ \(0\)\
\-\ wings\\:\\ 0\\.058070140120592716\ \(0\)\
\-\ this\\:\\ 0\\.057854173855333674\ \(0\)\
\-\ less\\:\\ 0\\.057271658995898145\ \(0\)\
\-\ parasellar\\:\\ 0\\.05708482545337321\ \(0\)\
\-\ cases\\:\\ 0\\.056622440297655674\ \(0\)\
\-\ parasagittal\\:\\ 0\\.05621571632254729\ \(0\)\
\-\ white\\:\\ 0\\.055542119239709906\ \(0\)\
\-\ expressive\\:\\ 0\\.055438271712833845\ \(0\)\
\-\ stimulate\\:\\ 0\\.055438271712833845\ \(0\)\
\-\ often\\:\\ 0\\.05492995690265928\ \(0\)\
\-\ buckling\\:\\ 0\\.054092939349196185\ \(0\)\
\-\ by\\:\\ 0\\.05362401780652739\ \(0\)\
\-\ olfactory\\:\\ 0\\.052955477043064574\ \(0\)\
\-\ only\\:\\ 0\\.05259329402642086\ \(0\)\
\-\ brain\\:\\ 0\\.052479989837497215\ \(0\)\
\-\ t1\\:\\ 0\\.052451799192601206\ \(0\)\
\-\ vault\\:\\ 0\\.05244638560865682\ \(0\)\
\-\ groove\\:\\ 0\\.05244638560865682\ \(0\)\
\-\ densely\\:\\ 0\\.05244638560865682\ \(0\)\
\-\ meninges\\:\\ 0\\.05110105324501916\ \(0\)\
\-\ dysarthria\\:\\ 0\\.0507020966769318\ \(0\)\
\-\ opposite\\:\\ 0\\.049620324439351896\ \(0\)\
\-\ explained\\:\\ 0\\.049620324439351896\ \(0\)\
\-\ compresses\\:\\ 0\\.049292319370401856\ \(0\)\
\-\ thirds\\:\\ 0\\.04897827627166804\ \(0\)\
\-\ t2\\:\\ 0\\.04843329277215591\ \(0\)\
\-\ aspirin\\:\\ 0\\.048387649211434604\ \(0\)\
\-\ comes\\:\\ 0\\.048387649211434604\ \(0\)\
\-\ phenomenon\\:\\ 0\\.048387649211434604\ \(0\)\
\-\ hyperostosis\\:\\ 0\\.048387649211434604\ \(0\)\
\-\ lesions\\:\\ 0\\.04834774007971862\ \(0\)\
\-\ description\\:\\ 0\\.04810916714084213\ \(0\)\
\-\ supratentorial\\:\\ 0\\.04784081396553643\ \(0\)\
\-\ sharply\\:\\ 0\\.04758187865884522\ \(0\)\
\-\ cerebellopontine\\:\\ 0\\.04708976973839574\ \(0\)\
\-\ aphasia\\:\\ 0\\.04685549929831693\ \(0\)\
\-\ consisting\\:\\ 0\\.04685549929831693\ \(0\)\
\-\ predominance\\:\\ 0\\.04662843833517487\ \(0\)\
\-\ attachment\\:\\ 0\\.046408156333518115\ \(0\)\
\-\ refractory\\:\\ 0\\.046194260224997064\ \(0\)\
\-\ interface\\:\\ 0\\.04598639016749102\ \(0\)\
\-\ dura\\:\\ 0\\.04578421590267054\ \(0\)\
\-\ impairment\\:\\ 0\\.044848927861359404\ \(0\)\
\-\ peripherally\\:\\ 0\\.04467529869619052\ \(0\)\
\-\ distortion\\:\\ 0\\.04450566136182375\ \(0\)\
\-\ associated\\:\\ 0\\.04437120193258727\ \(0\)\
\-\ was\\:\\ 0\\.04400835783818699\ \(0\)\
\-\ intraventricular\\:\\ 0\\.0438636131941399\ \(0\)\
\-\ most\\:\\ 0\\.043811824809363666\ \(0\)\
\-\ planes\\:\\ 0\\.04341627022934109\ \(0\)\
\-\ peak\\:\\ 0\\.04313243142598503\ \(0\)\
\-\ ages\\:\\ 0\\.042994504063313996\ \(0\)\
\-\ account\\:\\ 0\\.042859107621284386\ \(0\)\
\-\ provide\\:\\ 0\\.042595547495226635\ \(0\)\
\-\ sphenoid\\:\\ 0\\.04234107748310907\ \(0\)\
\-\ supply\\:\\ 0\\.04234107748310907\ \(0\)\
\-\ have\\:\\ 0\\.0420544507506662\ \(0\)\
\-\ nearly\\:\\ 0\\.041975106660867595\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.041975106660867595\ \(0\)\
\-\ neurofibromatosis\\:\\ 0\\.041740836220788786\ \(0\)\
\-\ transient\\:\\ 0\\.04140281227853069\ \(0\)\
\-\ multiple\\:\\ 0\\.0411761532715207\ \(0\)\
\-\ fissure\\:\\ 0\\.04107959714746892\ \(0\)\
\-\ primarily\\:\\ 0\\.040376312951515114\ \(0\)\
\-\ atrophy\\:\\ 0\\.03982263588866152\ \(0\)\
\-\ half\\:\\ 0\\.039646939515450605\ \(0\)\
\-\ nonspecific\\:\\ 0\\.039560635618662375\ \(0\)\
\-\ adults\\:\\ 0\\.039307620006679166\ \(0\)\
\-\ anatomic\\:\\ 0\\.03906299321534557\ \(0\)\
\-\ images\\:\\ 0\\.03894063535320747\ \(0\)\
\-\ frequent\\:\\ 0\\.03859680247769965\ \(0\)\
\-\ episodes\\:\\ 0\\.03844772873971005\ \(0\)\
\-\ arachnoid\\:\\ 0\\.03844772873971005\ \(0\)\
\-\ normally\\:\\ 0\\.038374306252753135\ \(0\)\
\-\ which\\:\\ 0\\.03827923423876688\ \(0\)\
\-\ isointense\\:\\ 0\\.038087711043291894\ \(0\)\
\-\ broad\\:\\ 0\\.03801776834845689\ \(0\)\
\-\ expected\\:\\ 0\\.03794848240223678\ \(0\)\
\-\ association\\:\\ 0\\.037879840985785854\ \(0\)\
\-\ invasion\\:\\ 0\\.037545897164758486\ \(0\)\
\-\ numbness\\:\\ 0\\.037416439474806204\ \(0\)\
\-\ homogeneous\\:\\ 0\\.037164144845681334\ \(0\)\
\-\ hypointense\\:\\ 0\\.03704116034780244\ \(0\)\
\-\ angle\\:\\ 0\\.036920192080295476\ \(0\)\
\-\ margin\\:\\ 0\\.036920192080295476\ \(0\)\
\-\ that\\:\\ 0\\.036532633925949826\ \(0\)\
\-\ local\\:\\ 0\\.036233287245246486\ \(0\)\
\-\ reactive\\:\\ 0\\.036124772068129266\ \(0\)\
\-\ gray\\:\\ 0\\.03601782963020013\ \(0\)\
\-\ visual\\:\\ 0\\.03591241499372742\ \(0\)\
\-\ admission\\:\\ 0\\.03511928727703095\ \(0\)\
\-\ represent\\:\\ 0\\.03502588224427986\ \(0\)\
\-\ resulting\\:\\ 0\\.03502588224427986\ \(0\)\
\-\ 70\\:\\ 0\\.03475255843957922\ \(0\)\
\-\ growth\\:\\ 0\\.03470797281113338\ \(0\)\
\-\ seizures\\:\\ 0\\.03436066639961191\ \(0\)\
\-\ displacement\\:\\ 0\\.03431838032940141\ \(0\)\
\-\ parenchyma\\:\\ 0\\.034192956929151024\ \(0\)\
\-\ skull\\:\\ 0\\.03415161845096157\ \(0\)\
\-\ external\\:\\ 0\\.03402897464606969\ \(0\)\
\-\ characteristic\\:\\ 0\\.03402897464606969\ \(0\)\
\-\ site\\:\\ 0\\.03394833013781743\ \(0\)\
\-\ calcified\\:\\ 0\\.03390833600707489\ \(0\)\
\-\ intracranial\\:\\ 0\\.033868557479162426\ \(0\)\
\-\ 45\\:\\ 0\\.033750492575477214\ \(0\)\
\-\ around\\:\\ 0\\.03359595500972388\ \(0\)\
\-\ administration\\:\\ 0\\.033519883211661924\ \(0\)\
\-\ coronal\\:\\ 0\\.033519883211661924\ \(0\)\
\-\ arising\\:\\ 0\\.03344458766997792\ \(0\)\
\-\ arteries\\:\\ 0\\.033407226075941564\ \(0\)\
\-\ formation\\:\\ 0\\.03337005270232068\ \(0\)\
\-\ located\\:\\ 0\\.03329626309682552\ \(0\)\
\-\ not\\:\\ 0\\.0332337815029512\ \(0\)\
\-\ single\\:\\ 0\\.03236622134017035\ \(0\)\
\-\ sagittal\\:\\ 0\\.03236622134017035\ \(0\)\
\-\ hypertension\\:\\ 0\\.03220615217708601\ \(0\)\
\-\ history\\:\\ 0\\.03216310420944239\ \(0\)\
\-\ mass\\:\\ 0\\.03215598343819903\ \(0\)\
\-\ vertebral\\:\\ 0\\.032143084279836934\ \(0\)\
\-\ pressure\\:\\ 0\\.03204948176815319\ \(0\)\
\-\ base\\:\\ 0\\.03201854294271088\ \(0\)\
\-\ related\\:\\ 0\\.031987733298544256\ \(0\)\
\-\ 18\\:\\ 0\\.0318960687774318\ \(0\)\
\-\ rate\\:\\ 0\\.0318960687774318\ \(0\)\
\-\ rare\\:\\ 0\\.03177559427993692\ \(0\)\
\-\ 13\\:\\ 0\\.03174578050581132\ \(0\)\
\-\ occur\\:\\ 0\\.030956444033640406\ \(0\)\
\-\ based\\:\\ 0\\.030490253295994484\ \(0\)\
\-\ grade\\:\\ 0\\.030267757071047962\ \(0\)\
\-\ intensity\\:\\ 0\\.02988805148976763\ \(0\)\
\-\ identified\\:\\ 0\\.02984193322053161\ \(0\)\
\-\ extension\\:\\ 0\\.029796101402020426\ \(0\)\
\-\ would\\:\\ 0\\.029796101402020426\ \(0\)\
\-\ effect\\:\\ 0\\.02952693238293504\ \(0\)\
\-\ new\\:\\ 0\\.02911986522387576\ \(0\)\
\-\ does\\:\\ 0\\.029099050262096346\ \(0\)\
\-\ headache\\:\\ 0\\.029016372656997667\ \(0\)\
\-\ benign\\:\\ 0\\.028914311568541545\ \(0\)\
\-\ masses\\:\\ 0\\.02865537626185034\ \(0\)\
\-\ thickening\\:\\ 0\\.028635829497949072\ \(0\)\
\-\ size\\:\\ 0\\.028500433055919466\ \(0\)\
\-\ followed\\:\\ 0\\.028424164686408366\ \(0\)\
\-\ internal\\:\\ 0\\.02836747632264337\ \(0\)\
\-\ type\\:\\ 0\\.028236872929861715\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.028181600019297388\ \(0\)\
\-\ vascular\\:\\ 0\\.027788442193400608\ \(0\)\
\-\ past\\:\\ 0\\.02739865082219119\ \(0\)\
\-\ between\\:\\ 0\\.027349293453827857\ \(0\)\
\-\ 20\\:\\ 0\\.02715510069228181\ \(0\)\
\-\ medical\\:\\ 0\\.026751102170422765\ \(0\)\
\-\ show\\:\\ 0\\.026720922582104\ \(0\)\
\-\ clinical\\:\\ 0\\.026675883383933844\ \(0\)\
\-\ age\\:\\ 0\\.026425727256217293\ \(0\)\
\-\ enhancing\\:\\ 0\\.026368079314114695\ \(0\)\
\-\ yo\\:\\ 0\\.02629664701321043\ \(0\)\
\-\ artery\\:\\ 0\\.02614188845286124\ \(0\)\
\-\ negative\\:\\ 0\\.02605882304594627\ \(0\)\
\-\ years\\:\\ 0\\.02580178682536972\ \(0\)\
\-\ month\\:\\ 0\\.025605004522102844\ \(0\)\
\-\ abnormal\\:\\ 0\\.02528826495008568\ \(0\)\
\-\ following\\:\\ 0\\.02525115389587883\ \(0\)\
\-\ focal\\:\\ 0\\.025177487070470662\ \(0\)\
\-\ all\\:\\ 0\\.02505632015977906\ \(0\)\
\-\ two\\:\\ 0\\.02499647474611347\ \(0\)\
\-\ he\\:\\ 0\\.024925295103575034\ \(0\)\
\-\ if\\:\\ 0\\.024456454461732065\ \(0\)\
\-\ blood\\:\\ 0\\.024445383343289447\ \(0\)\
\-\ significant\\:\\ 0\\.02430295028286618\ \(0\)\
\-\ therapy\\:\\ 0\\.024184540900804685\ \(0\)\
\-\ signal\\:\\ 0\\.023860715590377828\ \(0\)\
\-\ mild\\:\\ 0\\.023860715590377828\ \(0\)\
\-\ than\\:\\ 0\\.023860715590377828\ \(0\)\
\-\ who\\:\\ 0\\.02380979130918468\ \(0\)\
\-\ anterior\\:\\ 0\\.023501671299284977\ \(0\)\
\-\ both\\:\\ 0\\.02347252485299767\ \(0\)\
\-\ symptoms\\:\\ 0\\.02303031702016871\ \(0\)\
\-\ consistent\\:\\ 0\\.02282320802697748\ \(0\)\
\-\ upper\\:\\ 0\\.022493272875345888\ \(0\)\
\-\ man\\:\\ 0\\.022283987744663048\ \(0\)\
\-\ without\\:\\ 0\\.022201907932174064\ \(0\)\
\-\ can\\:\\ 0\\.022088508788402614\ \(0\)\
\-\ demonstrate\\:\\ 0\\.021882425172996506\ \(0\)\
\-\ mri\\:\\ 0\\.02160625950457586\ \(0\)\
\-\ present\\:\\ 0\\.021598733854706023\ \(0\)\
\-\ demonstrates\\:\\ 0\\.02114652543853144\ \(0\)\
\-\ lateral\\:\\ 0\\.02088929801266206\ \(0\)\
\-\ up\\:\\ 0\\.020821289244992564\ \(0\)\
\-\ contrast\\:\\ 0\\.020451606977372548\ \(0\)\
\-\ female\\:\\ 0\\.020311295248164534\ \(0\)\
\-\ also\\:\\ 0\\.019798835222482675\ \(0\)\
\-\ as\\:\\ 0\\.01690982015466892\ \(0\)\
\-\ there\\:\\ 0\\.01674824635000673\ \(0\)\
\-\ ct\\:\\ 0\\.016024791062850464\ \(0\)\
\-\ at\\:\\ 0\\.015898652964642455\ \(0\)\
\-\ left\\:\\ 0\\.014358473662742269\ \(0\)\
\-\ right\\:\\ 0\\.013955214745748401\ \(0\)\
